Announcing a new collaboration with Takeda

Press Release

Announcing a new collaboration with Takeda

Press Release

Partnering & licensing

Partners

Partnering to make drug development designable

Interested to learn more about partnering and licensing opportunities?

Contact Us

Partner with us

01

Platform

We collaborate with leading pharmaceutical companies to embed our AI-driven, wet-lab-integrated platform across their discovery pipelines. These partnerships enable partners to design biologics — from antibodies to multispecifics to other custom biologics — with drug-like properties from the start, expanding the range of targets, formats, and modalities that can be addressed.

02

Licensing

Nabla also develops a growing portfolio of designed biologics against high-value disease targets. We license these molecules to partners with deep development expertise to accelerate their path to patients and maximize clinical impact.